SA
ELAN icon

Strategic Advocates’s Elanco Animal Health ELAN Stock Holding History

Strategic Advocates’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14
Closed -$319 – 363
2025
Q4 		$319 Hold
14
– – ﹤0.01% 569
2025
Q3 		$282 Buy
+14
New +$235 ﹤0.01% 550

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Strategic Advocates's ELAN Position: Q1 2026 in Review

Strategic Advocates sold out of Elanco Animal Health (ELAN) in Q1 2026, closing a stake of 14 shares — an estimated $319 sold.

Strategic Advocates first reported a position in ELAN in Q3 2025 and held it in 2 quarters. The position peaked at $319 in Q4 2025. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Strategic Advocates reported no remaining Elanco Animal Health position as of Q1 2026 after selling out during the quarter.
  • Strategic Advocates sold 14 Elanco Animal Health shares in Q1 2026, an estimated $319.
  • Strategic Advocates first reported a position in Elanco Animal Health in Q3 2025 and held it in 2 quarters.
  • Strategic Advocates's Elanco Animal Health position peaked at $319 in Q4 2025.
  • 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.